Tissue-specific deletion of the retinoblastoma protein in the pancreatic β-cell has limited effects on β-cell replication, mass, and function

Diabetes

Volumn 56, Issue 1, 2007, Pages 57-64

  Vasavada, Rupangi C ^a   Cozar Castellano, Irene ^a   Sipula, Darinka ^a   Stewart, Andrew F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; PROTEIN P107; PROTEIN P130; RETINOBLASTOMA PROTEIN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE ARREST; CELL DIVISION; CELL FUNCTION; CELL VOLUME; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE INACTIVATION; GLUCOSE BLOOD LEVEL; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TISSUE SPECIFICITY; UPREGULATION;

ANIMALS; CELL CYCLE; CELL DIVISION; GENE DELETION; GENE EXPRESSION REGULATION; INSULIN-SECRETING CELLS; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; POLYMERASE CHAIN REACTION; RETINOBLASTOMA PROTEIN;

EID: 33847035971     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0517     Document Type: Article

References (50)

1. Cozar-Castellano I, Fiaschi-Taesch N, Bigatel TA, Takane KK, Garcia-Ocana A, Vasavada RC, Stewart AF: Molecular control of cell cycle progression in the pancreatic beta cell. Endocr Rev 27:356-370, 2006
2. Swenne I: Glucose-stimulated DNA replication in the pancreatic islets during the development of the rat fetus. Diabetes 34:803-807, 1985
3. Finegood DT, Scaglia L, Bonner-Weir S: Dynamics of β-cell mass in the growing rat pancreas: estimation with a simple mathematical model. Diabetes 44:249-256, 1995
4. Teta M, Long SY, Wartschow LM, Rankin MM, Kushner JA: Very slow turnover of β-cells in aged adult mice. Diabetes 54:2557-2567, 2005
5. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: β-Cell deficit and increased β-cell apoptosis in humans with diabetes. Diabetes 52:102-110, 2003
6. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B: β-Cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 49:1325-1333, 2000
7. Dor Y, Brown J, Martinez OI, Melton DA: Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41-46, 2004
8. 1. Diabetes 53:149-159, 2004
9. Garcia-Ocaña A, Vasavada RC, Takane KK, Cebrian A, Lopez-Talavera JC, Stewart AF: Using beta-cell growth factors to enhance human pancreatic islet transplantation. J Clin Endocrinol Metab 86:984-988, 2001
10. Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y: Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol 20:6147-6158, 2000
11. Fatrai S, Elghazi L, Balcazar N, Cras-Meneur C, Krits I, Kiyokawa H, Bernal-Mizrachi E: Akt induces β-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes 55:318-325, 2006
12. cip. Diabetes 55:70-77, 2006
13. Karnik SK, Hughes CM, Gu X, Rozenblatt-Rosen O, McClean GW, Xiong Y, Meyerson M, Kim SK: Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27kip1 and p18Ink4c. Proc Natl Acad Sci U S A 102:14659-14664, 2005
14. Uchida T, Nakamura T, Hashimoto N, Matsuda T, Kotani K, Sakaue H, Kido Y, Hayashi Y, Nakayama KI, White MF, Kasuga M: Deletion of cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med 11:175-182, 2005
15. KIP2 expression in normal islet cells and in hyperinsulinism of infancy. Diabetes 50:2763-2769, 2001
16. Hanahan D: Heritable formation of pancreatic β-cell tumors in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315:115-122, 1985
17. Efrat S, Linde S, Kofod H, Spector D, Delannoy M, Grant S, Hanahan D, Baekkeskov S: Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci U S A 85:9037-9041, 1988
18. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A: The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 20:501-534, 1999
19. Pagano M, Jackson PK: Wagging the dogma: tissue-specific cell cycle control in the mouse embryo. Cell 118:535-538, 2004
20. Munger K: Clefts, grooves and (small) pockets: the structure of the retinoblastoma tumor suppressor in complex with its cellular target E2F unveiled. Proc Nat Acad Sci U S A 100:2165-2167, 2005
21. Chau BN, Wang JYJ: Coordinated regulation of life and death by RB. Nat Rev Cancer 3:130-138, 2003
22. Berns A: Timing will tell. Science 424:140-141, 2003
23. Hernando E, Nahle Z, Juan G, Diaz-Rodriguez, Alaminos M, Hemann M, Michel L, Mittal V, Gerald W, Benezra R, Lowe SW, Cordon-Cardo C: Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Science 430:797-802, 2004
24. Rane S, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M: Loss of expression of cdk4 causes insulin-deficient diabetes and cdk4 activation results in beta cell hyperplasia. Nat Genet 22:44-52, 1999
25. Tsutsui T, Hesabi B, Moons D, Pandolfi PP, Hansel KS, Koff A, Kiyokawa H: Targeted disruption of cdk4 delays cell cycle entry with enhanced p27-kip activity. Mol Cell Biol 19:7011-7019, 1999
26. Georgia S, Bhushan A: β Cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest 114:963-968, 2004
27. Kushner J, Ciemerych MA, Sicinska E, Wartschow LM, Teta M, Long SY, Sicinski P, White MF: Cyclins D2 and D1 are essential for postnatal pancreatic beta cell growth. Mol Cell Biol 25:3752-3762, 2005
28. Zhang X, Gaspard JP, Mizukami Y, Li J, Graeme-Cook F, Chung DC: Overexpression of cyclin D1 in pancreatic β-cells in vivo results in islet hyperplasia without hypoglycemia. Diabetes 54:712-719, 2005
29. Harvey M, Vogel H, Lee EY-P, Bradley A, Donehower LA: Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res 55:1146-1151, 1995
30. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T: Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 7:480-484, 1994
31. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell M, Weinberg RA: Effects of an Rb mutation in the mouse. Nature 359:295-300, 1992
32. Marino S, Vooijs M, van der Gulden H, Jonkers J, Berns A: Induction of medulloblastomas in p53-mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev 14:994-1004, 2000
33. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, Shelton KD, Lindner J, Cherrington AD, Magnuson MA: Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem 274:305-315, 1999
34. Roccisana J, Reddy V, Vasavada RC, Gonzalez-Pertusa JA, Magnuson MA, Garcia-Ocana A: Targeted inactivation of hepatocyte growth factor receptor c-met in β-cells leads to defective insulin secretion and GLUT-2 downregulation without alteration of β-cell mass. Diabetes 54:2090-2102, 2005
35. Vasavada RC, Garcia-Ocaña A, Zawalich WS, Sorenson RL, Dann PS, Ogren L, Talamantes F, Stewart AF: Targeted expression of placental lactogen in the beta cells of transgenic mice results in beta cell proliferation, islet mass augmentation, and hypoglycemia. J Biol Chem 275:15399-15406, 2000
36. Fujinaka Y, Sipula D, Garcia-Ocana A, Vasavada RC: Characterization of mice doubly transgenic for parathyroid hormone-related protein and murine placental lactogen: a novel role for placental lactogen in pancreatic β-cell survival. Diabetes 53:3120-3130, 2004
37. Garcia-Ocaña A, Vasavada RC, Cebrian A, Reddy V, Takane KK, Lopez-Talavera J-C, Stewart AF: Transgenic overexpression of hepatocyte growth factor in the β-cell markedly improves islet function and islet transplant outcomes. Diabetes 50:2752-2762, 2001
38. Cabrera O, Berman D, Kenyon NS, Ricordi C, Berggren P-O, Caicedo A: The unique architecture of the human pancreatic islet has implications for islet cell function. Proc Natl Acad Sci U S A 103:2334-2339, 2006
39. Cobrinik D: Pocket proteins and cell cycle control. Oncogene 24:2796-2809, 2005
40. Jiang Z, Zacksenhaus E, Gallie BL, Phillips RA: The retinoblastoma gene family is differentially expressed during embryogenesis. Oncogene 14:1789-1797, 1997
41. LeCouter JE, Kablar B, Hardy WR, Ying C, Megeney LA, May LL, Rudnicki MA: Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the pRb-related p107 gene. Mol Cell Biol 18:7455-7465, 1998
42. LeCouter JE, Kablar B, Whyte PF, Ying C, Rudnicki MA: Strain dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. Development 125:4669-4665, 1998
43. Paggi MG, Giordano A: Who is the boss in the retinoblastoma family? The point of view of Rb2/p130, the little brother. Cancer Res 61:4651-4654, 2001
44. Knudson AG: Cancer genetics. Am J Med Genet 111:96-102, 2002
45. Kulkarni RN, Almind K, Goren HJ, Winnay JN, Ueki K, Okada T, Kahn CR: Impact of genetic background on development of hyperinsulinemia and diabetes in insulin receptor/insulin receptor substrate-1 double heterozygous mice. Diabetes 52:1528-1534, 2003
46. Bock T, Pakkenberg B, Buschard K: Increased islet volume but unchanged islet number in ob/ob mice. Diabetes 52:1716-1722, 2003
47. Wu L, de Bruin A, Saavedra HI, Starovic M, Trimboli A, Yang Y, Opavska J, Wilson P, Thompson JC, Ostrowski MC, Rosol TJ, Woollett LA, Weinstein M, Cross JC, Robinson M, Leone G: Extra-embryonic function of Rb is essential for embryonic development and viability. Nature 421:942-947, 2003
48. 1 control and immortalization. Genes Dev 14:3037-3050, 2000
49. Sage J, Miller AL, Perez-Mancera PA, Wysocki JM, Jacks T: Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424:223-227, 2003
50. Lee JY, Ristow M, Lin X, White MF, Magnuson MF, Henninghausen L: RIP-Cre revisited: evidence for impairments of pancreatic β-cell function. J Biol Chem 281:2649-2653, 2006